Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

QTTB Q32 Bio Inc

3,495

-0,025 (-0,71%)

Zuletzt aktualisiert: 16:28:50

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Q32 Bio (NASDAQ:QTTB)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Q32 Bio Charts.

Q32 Bio (NASDAQ:QTTB)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Q32 Bio Charts.

News Q32 Bio Inc

Form 8-K - Current report
Montag 13 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Mittwoch 11 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 11 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program
Dienstag 10 Dezember 2024 (2 Monate vor) • PR Newswire (US)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Donnerstag 7 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Donnerstag 7 November 2024 (3 Monate vor) • PR Newswire (US)

Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference
Dienstag 5 November 2024 (3 Monate vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 17 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024
Montag 14 Oktober 2024 (3 Monate vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 10 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Q32 Bio Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen